• OPEN AN ACCOUNT
Indian Indices
Nifty
24,968.40 -143.05
(-0.57%)
Sensex
81,757.73 -501.51
( -0.61%)
Bank Nifty
56,283.00 -545.80
( -0.96%)
Nifty IT
37,141.85 3.30
( 0.01%)
Global Indices
Nasdaq
44,363.41 142.09
(-0.32%)
Dow Jones
6,317.35 -1.01
(-0.02%)
Hang Seng
39,788.57 -112.62
(-0.28%)
Nikkei 225
8,992.12 19.48
(0.22%)
Forex
USD-INR
85.99 0.08
(0.09%)
EUR-INR
99.75 -0.09
(-0.09%)
GBP-INR
115.25 0.11
(0.09%)
JPY-INR
0.58 0.00
(0.02%)

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
91669
INE0PLZ01012
37.7078673
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNREST
11.37
22.74
EPS(TTM)
Face Value()
Div & Yield %
4.66
10
0
 

gateway distriparks ltd
NCL Research and Financial Services standalone net profit declines 58.33% in the March 2025 quarter
Jun 01,2025
Net profit of NCL Research and Financial Services declined 58.33% to Rs 0.10 crore in the quarter ended March 2025 as against Rs 0.24 crore during the previous quarter ended March 2024. Sales declined 71.94% to Rs 2.02 crore in the quarter ended March 2025 as against Rs 7.20 crore during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 1.36 crore in the year ended March 2025 as against net profit of Rs 1.61 crore during the previous year ended March 2024. Sales declined 20.21% to Rs 8.53 crore in the year ended March 2025 as against Rs 10.69 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales2.027.20 -72 8.5310.69 -20
OPM %37.62-14.17 --8.6810.20 -
PBDT0.140.18 -22 -0.602.03 PL
PBT0.120.16 -25 -0.661.98 PL
NP0.100.24 -58 -1.361.61 PL